CHRS Technical

Technical Sentiment Analysis for Coherus Oncology Inc (CHRS) As of 2026-05-11, Coherus Oncology Inc (CHRS) is exhibiting a Strong Buy technical sentiment. Our proprietary analysis, which aggregates 14 technical signals, shows that 13 indicators are flashing buy, while 1 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for CHRS stands at 62.893, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.0192, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 38.264 and the Commodity Channel Index (CCI) at 178.499 further confirm a 0.145 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, CHRS is trading above its 60-day moving average of $1.73 and above its 200-day long-term moving average of $1.539. Key price levels to watch include the immediate resistance at $2.026 and strong support at $1.622. A break above $2.026 could signal a bull continuation, while falling below $1.622 may test the next Fibonacci floor at $1.46.